Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
85 /100
CRITICAL RISK
Score updated Oct 13, 2026

ENVB — Enveric Biosciences, Inc. Dilution Risk Tracker

Track ENVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENVB — Get alerts when the score changes →

As of October 13, 2026, Enveric Biosciences, Inc. (ENVB) has a DilutionWatch DilutionScore of 85/100, rated CRITICAL dilution risk. Enveric Biosciences, Inc. has a market capitalization of $6.58M, 4.48M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $10.00M, ATM program capacity of $1.35M, 1.38M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
22
⚠️ Warrant Exposure
70
🔄 Convertible Debt
15

Dilution Forecast

🌩️
Severe
Multiple high-probability dilution events detected
model est. 64%
💰 Capital Raise model 93%
• Critical: only 2.8 months cash remaining
• Active shelf registration ($10M, 152% of market cap)
📜 Warrant Exercise model 50%
• Massive warrant overhang: 31% of shares outstanding
• Elevated warrant risk score (70/100)
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
🔔 Track ENVB — Get forecast alerts →

Market Data

Market Cap$6.58M
Shares Outstanding4.48M
Float3.64M
Cash$2.92M
Debt$3.49M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore85/100DilutionWatch score record
Shares Outstanding4.48MVerified float table or market cache
Public Float3.64MVerified float table or market cache
Market Cap$6.58MMarket data cache
Cash Runway2.8 monthsDilutionWatch score inputs
Shelf Capacity$10.00MSEC-derived dilution fields
ATM Capacity$1.35MSEC-derived dilution fields
Outstanding Warrants1.38MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B3 2, 8-K 1, EFFECT 1, S-3 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 24.2K shares
#1 AdvisorShares Investments, LLC 17.0K shares
#2 UBS Group AG 2.9K shares
#3 Citigroup Inc. 2.3K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest15.4K
Days to Cover1.0
% of Float0.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-27
xbrl XBRL CONVERTIBLE 2022-03-31
EFFECT EFFECT 2026-04-29
424B3 ATM 2026-04-29
S-3 SHELF 2026-04-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ENVB Dilution Snapshot

Enveric Biosciences, Inc. (ENVB) has a DilutionScore of 85/100, rated Critical dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ENVB's DilutionScore is currently 85/100 (Critical risk), with 3 score changes tracked over 89 days. The score improved from 75/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202685/100CRITICAL13 days
Aug 22 – Sep 30, 202675/100HIGH40 days
Aug 14 – Aug 21, 202692/100CRITICAL7 days
Jul 16 – Aug 13, 202675/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ENVB shares outstanding have increased 164.8% from 1.39M (Mar 2026) to 3.68M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 20263.68M3.64M▲ 0.94%
Apr 24, 20261.99M1.85M▲ 0.11%
Apr 07, 20261.89M1.85M▲ 7.06%
Mar 11, 20261.39M545.9K▲ 5.90%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ENVB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ENVB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ENVB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ENVB
ENVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.